01 April 2014
01 April 2014
FutureCarbon and Bayer MaterialScience have signed an agreement stating FutureCarbon will acquire the bulk of Bayer‘s corresponding patents related to Carbon Nanotube (CNT) and Graphene.
“We enjoy a long-standing development partnership with Bayer. We are pleased that we were able to acquire the Bayer patents for further market realisation of the technology. They expand our applications base substantially and open up new possibilities and business segments for us,” said Dr. Walter Schütz, FutureCarbon’s Managing Director of Development.
“We are happy that FutureCarbon, one of the partners from the Inno.CNT development network, will be carrying on our company’s work,” said Patrick Thomas, CEO of Bayer Material Science. “We are confident that the technology harbours tremendous potential, particularly for a renowned specialist company like FutureCarbon.”
Bayer MaterialScience explain its researchers have conducted substantial research and development work in the field of carbon nanotubes in collaboration with external partners over the last 10 years. The intellectual property that has been built-up includes complex issues relating to safe production and methods for scaling up the production processes. Next-generation catalysts and new product grades were also developed.
“FutureCarbon does further strengthen its unique market position in the application specific utilisation of the amazing material effects of CNT’s and graphene’s through this agreement. Exciting pioneering materials such as glass- and carbon-fibre-reinforced plastics will be boosted in terms of weight, strength and efficiency through our solutions “, concludes Klaus Zeyn, Managing Director Sales & Marketing of FutureCarbon.
The financial details of the transfer will not be disclosed.